<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Death Discov</journal-id><journal-id journal-id-type="iso-abbrev">Cell Death Discov</journal-id><journal-title-group><journal-title>Cell Death Discovery</journal-title></journal-title-group><issn pub-type="epub">2058-7716</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39890775</article-id><article-id pub-id-type="pmc">PMC11785755</article-id><article-id pub-id-type="publisher-id">2316</article-id><article-id pub-id-type="doi">10.1038/s41420-025-02316-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Regulatory roles of RNA binding proteins in the Hippo pathway</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Peng</surname><given-names>Shuchang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Chenglin</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0009-6554-5793</contrib-id><name><surname>He</surname><given-names>Yanwen</given-names></name><address><email>185838305@qq.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4495-0414</contrib-id><name><surname>Xue</surname><given-names>Lei</given-names></name><address><email>lei.xue@tongji.edu.cn</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8707-7849</contrib-id><name><surname>Guo</surname><given-names>Xiaowei</given-names></name><address><email>xiaoweiguo@hunnu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/053w1zy07</institution-id><institution-id institution-id-type="GRID">grid.411427.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0089 3695</institution-id><institution>The Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, School of Basic Medical Sciences, </institution><institution>Hunan Normal University, </institution></institution-wrap>Changsha, China </aff><aff id="Aff2"><label>2</label>The Engineering Research Center of Reproduction and Translational Medicine of Hunan Province, Changsha, China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03rc6as71</institution-id><institution-id institution-id-type="GRID">grid.24516.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 2370 4535</institution-id><institution>Department of Nuclear Medicine, Shanghai 10th People&#x02019;s Hospital, School of Life Science and Technology, </institution><institution>Tongji University, </institution></institution-wrap>Shanghai, China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qfq0x09</institution-id><institution-id institution-id-type="GRID">grid.488482.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1765 5169</institution-id><institution>Changsha Stomatological Hospital, </institution><institution>Hunan University of Chinese Medicine, </institution></institution-wrap>Changsha, China </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>11</volume><elocation-id>36</elocation-id><history><date date-type="received"><day>1</day><month>9</month><year>2024</year></date><date date-type="rev-recd"><day>25</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>21</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The Hippo pathway represents a highly conserved evolutionary pathway, dysfunction of which has been implicated in various diseases. RNA-binding proteins (RBPs) intricately modulate gene expression through interacting with non-coding RNAs or other proteins. To data, while an array of RBPs have been identified as modulators of the Hippo pathway, there remains a notable absence of a comprehensive review addressing the mechanistic regulations of RBPs in the transduction of Hippo signaling. Herein, this review aims to consolidate recent advances and elucidate the intricate mechanisms underlying RBPs binding to target RNA. It also explores the dynamic interplay between RBPs, non-coding RNAs, TFs, and DNA on chromatin. Additionally, it also outlines future perspectives, including the essential non-canonical functions of RBPs and emerging roles of non-canonical RBPs as transcription factors (TFs) in genes transcription. Overall, this review provides mechanistic insights into the roles of eukaryotic RBP proteins in the regulation of crucial signaling cascades.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Cell signalling</kwd><kwd>Molecular biology</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China (National Science Foundation of China)</institution></institution-wrap></funding-source><award-id>32370760</award-id><principal-award-recipient><name><surname>Guo</surname><given-names>Xiaowei</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Cell Death Differentiation Association (ADMC) 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Facts</title><p id="Par2">
<list list-type="bullet"><list-item><p id="Par3">Dysfunction of the Hippo signaling pathway has been closely associated with various diseases including cancer.</p></list-item><list-item><p id="Par4">A multitude of RNA-binding proteins have been identified as regulators of the Hippo pathway through multiple canonical mechanisms including alternative splicing, stability, and translation.</p></list-item><list-item><p id="Par5">RNA-binding proteins, Non-coding RNAs and TFs collaborate to regulate gene expression.</p></list-item><list-item><p id="Par6">Modifications of RNA binding proteins in response to different stimuli affect the Hippo pathway.</p></list-item></list>
</p></sec><sec id="Sec2"><title>Open Questions</title><p id="Par7">
<list list-type="bullet"><list-item><p id="Par8">Can RNA-binding proteins regulate gene expression via non-canonical mechanisms independent of RNA-binding activity?</p></list-item><list-item><p id="Par9">Can a fraction of transcription factors function as RNA-binding proteins under specific conditions?</p></list-item><list-item><p id="Par10">Can RNA-binding proteins regulate the Hippo pathway in a feedback loop?</p></list-item></list>
</p></sec><sec id="Sec3" sec-type="introduction"><title>Introduction</title><p id="Par11">The Hippo signaling pathway, initially discovered in <italic>Drosophila</italic>, has been well-characterized as a conserved pathway that regulates organ size and tumorigenesis [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>]. A myriad of upstream signals, such as cell polarity, mechanical cues, cell density and stress stimuli [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], have been extensively demonstrated to modulate Hippo signaling across biological processes [<xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref>]. In brief, the core of Hippo pathway comprises a kinase cascade that the kinase Hippo in <italic>Drosophila</italic> (MST1/2 in mammals) phosphorylates the downstream kinase Warts (LATS1/2 in mammals), which in turn leads to the phosphorylation and inactivation of oncoprotein Yorkie (YAP/TAZ in mammals). Disruption of the Hippo pathway results in nuclear translocation of unphosphorylated Yki/YAP/TAZ. Subsequently, these proteins synergistically cooperate with Scalloped (Sd)/TEAD1-4 (Sd orthologs in mammals) to upregulate the expression of downstream target genes [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par12">Deregulation of the Hippo pathway has been deeply implicated in the development and various diseases. On one hand, extensive research has robustly established the oncogenic function of YAP/Yki, a fact that has been even succinctly featured in a collection of review articles. On the other hand, a growing number of studies have also bolstered the notion of the inhibitory roles of YAP/Yki. For instance, the loss of Yki/YAP markedly enhances cell migration in both <italic>Drosophila</italic> and human cancer cell lines [<xref ref-type="bibr" rid="CR14">14</xref>]. Oxidative stress reprograms Yki to switch from a pro-proliferative factor to an anti-proliferative agent, establishing a self-protective mechanism [<xref ref-type="bibr" rid="CR15">15</xref>]. In addition, it has been documented that the activation of YAP inhibits tumor growth in clear cell renal cell carcinoma, as well as in prostate and estrogen receptor &#x003b1;-positive breast cancers [<xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>]. To sum up, the Hippo-YAP pathway could execute either tumor-promoting or suppressive functions in a context-dependent manner.</p><p id="Par13">Numerous regulators of the Hippo signaling pathway have been identified successfully, primarily falling into the category of post-translational modification (PTM) enzymes, such as kinases, phosphatases, E3 ubiquitin ligases, methyltransferases, and deubiquitinating enzymes [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Besides, a multitude of RNA binding proteins (RBPs) have also been established as key regulators of the Hippo pathway. In brief, regulatory mechanisms of Hippo pathway by RBPs are typically associated with multiple RNA processing events, such as alternative splicing, mRNA stability, translation, and nuclear localization [<xref ref-type="bibr" rid="CR20">20</xref>]. Mounting evidence links the dysregulation of RBPs to the intricacies of normal development and a spectrum of diseases [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>], highlighting an intriguing interplay where RBPs and non-coding RNAs collaborate or compete to modulate gene expression [<xref ref-type="bibr" rid="CR19">19</xref>]. Mechanistically, RBPs can enhance or counteract the interaction between miRNAs and target RNAs through mediating RNA structural dynamics changes, or affecting miRNA access to the overlapping or proximal binding sites in RNA, and vice versa [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>].</p><p id="Par14">About the regulation of Hippo pathway by RBPs, it should the first report that heterogeneous nuclear ribonucleoprotein Hrb27C could regulate Yki phosphorylation in <italic>Drosophila</italic> via a yet unknown mechanism [<xref ref-type="bibr" rid="CR22">22</xref>]. In addition, our previous study provided compelling evidences that Rox8 recruits and stabilizes miRNA-8 to induce <italic>yki</italic> mRNA degradation, a mechanism highly conserved from <italic>Drosophila</italic> to humans [<xref ref-type="bibr" rid="CR19">19</xref>]. However, there remains a dearth of comprehensive reviews addressing the intricate interplay between the Hippo pathway and RBPs. Furthermore, this review also outlines perspectives on the future research concerning the functions of RBPs, aiming to enhance the understanding of their roles in the regulation of crucial signaling cascades.</p></sec><sec id="Sec4"><title>Mechanistic regulation of the Hippo pathway by RBPs</title><p id="Par15">A number of RBPs have been successfully identified as regulators of the Hippo pathway via multiple canonical mechanisms including mRNA stability, translation and alternative splicing. These regulatory processes often result in the dysregulation of cellular homeostasis during development and are implicated in a spectrum of diseases, including cancer, which were summarized as follows and listed in the Table <xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Regulation of the Hippo pathway by RBPs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Mechanistic Basis</th><th>RBP</th><th>Putative Target</th><th>Cancer Type</th><th>Reference</th></tr></thead><tbody><tr><td rowspan="13"><bold>mRNA Stability</bold></td><td>Dnd1</td><td>LATS2</td><td>hepatocellular carcinoma (HCC)</td><td>[<xref ref-type="bibr" rid="CR28">28</xref>]</td></tr><tr><td>FUS</td><td>LATS1/2</td><td>HCC</td><td>[<xref ref-type="bibr" rid="CR29">29</xref>]</td></tr><tr><td>RNPC1</td><td>MST1/2</td><td>&#x02014;</td><td>[<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td>METTL3</td><td>FZD10; LATS1</td><td>HCC; breast cancer</td><td>[<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td>YTHDF2</td><td>FZD10; LATS1; YAP</td><td>HCC; breast cancer; lung cancer</td><td>[<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td>IGF2BP1</td><td>SIK2</td><td>Non-small cell lung cancer (NSCLC)</td><td>[<xref ref-type="bibr" rid="CR35">35</xref>]</td></tr><tr><td>Rox8/TIAR</td><td>yki /YAP</td><td>lung cancer</td><td>[<xref ref-type="bibr" rid="CR19">19</xref>]</td></tr><tr><td>LIN28</td><td>MST1/2; LATS1/2</td><td>triple-negative breast cancer (TNBC)</td><td>[<xref ref-type="bibr" rid="CR36">36</xref>]</td></tr><tr><td>MSI2</td><td>MST1/2; LATS1/2; SAV1; MOB1</td><td>TNBC; pancreatic ductal adenocarcinoma (PDAC)</td><td>[<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td>QKI5</td><td>TAZ</td><td>ovarian cancer</td><td>[<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>ALKBH5</td><td>YAP</td><td>NSCLC</td><td>[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td>MEX3A</td><td>KIBRA</td><td>HCC</td><td>[<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td>hnRNPF</td><td>YAP</td><td>&#x02014;</td><td>[<xref ref-type="bibr" rid="CR42">42</xref>]</td></tr><tr><td rowspan="3"><bold>Translation</bold></td><td>YTHDF1</td><td>YAP</td><td>NSCLC</td><td>[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td>ALKBH5</td><td>YAP</td><td>NSCLC</td><td>[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td>MSI2</td><td>SAV1; MOB1</td><td>PDAC</td><td>[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td rowspan="3"><bold>Alternative Splicing</bold></td><td>ESRP2</td><td>NF2</td><td>Non-alcoholic fatty liver disease (NAFLD)</td><td>[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td>B52</td><td>yki</td><td>&#x02014;</td><td>[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td>RBFOX2</td><td>TEAD1</td><td>&#x02014;</td><td>[<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr></tbody></table><table-wrap-foot><p>This table summarizes the list of RBPs associated with the Hippo signaling pathway, including the mechanisms, putative targets, cancer types and selected references.</p></table-wrap-foot></table-wrap></p><sec id="Sec5"><title>mRNA stability</title><p id="Par16">It&#x02019;s a well-known notion that RBPs could increase the stability of target mRNA transcripts [<xref ref-type="bibr" rid="CR20">20</xref>]. For instance, ectopic expression of Dnd1 promotes <italic>LATS2</italic> mRNA decay through binding to the <italic>LATS2 3&#x02019;-UTR</italic>, thus promoting YAP phosphorylation and inhibiting Epithel-to-Mesenchymal Transformation (EMT) in hepatocellular carcinoma (HCC) [<xref ref-type="bibr" rid="CR28">28</xref>]. Similarly, enforced expression of FUS amplifies LATS1/2 expression to attenuate HCC progression by stabilizing <italic>LATS1/2</italic> mRNA [<xref ref-type="bibr" rid="CR29">29</xref>]. RNPC1 mitigates dryness in endothelial cells by enhancing <italic>MST1/2</italic> mRNA stability [<xref ref-type="bibr" rid="CR30">30</xref>]. It is noteworthy that an increasing number of studies have highlighted the dynamic and reversible m6A methylation process, which is an essential modification of eukaryotic RNAs involving RBP methyltransferases (Writers), demethylases (Erasers), and m6A-binding proteins (Readers) [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. In brief, typical writers consist of METTL3, METTL14 and WTAP, and the main erasers are FTO and ALKBH5, while YTHDF1-3 acts as m6A readers [<xref ref-type="bibr" rid="CR33">33</xref>]. For example, <italic>FZD10</italic> mRNA methylated by METTL3 is recognized by YTHDF2, thereby maintaining its stability in liver cancer cells [<xref ref-type="bibr" rid="CR34">34</xref>]. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) stabilized <italic>SIK2</italic> mRNA through m6A modification to promote non-small cell lung cancer (NSCLC) progression [<xref ref-type="bibr" rid="CR35">35</xref>]. As such, these studies demonstrate that RBPs could decrease mRNA stability.</p><p id="Par17">In addition, under certain conditions, RBPs could promote mRNA decay [<xref ref-type="bibr" rid="CR20">20</xref>]. For instance, our previous research has demonstrated that Rox8 recruits and stabilizes miRNA-8-RISCs binding to the 3&#x02019;UTR of <italic>yki</italic> mRNA, thereby leading to <italic>yki</italic> mRNA degradation [<xref ref-type="bibr" rid="CR19">19</xref>]. Two RBPs, LIN28 and MSI2, cooperate to induce the mRNA decay of YAP1 upstream kinases, including MST1/2 and LATS1/2, consequently inhibiting the Hippo pathway in triple-negative breast cancer (TNBC) [<xref ref-type="bibr" rid="CR36">36</xref>]. QKI5 directly binds and decreases <italic>TAZ</italic> mRNA stability in ovarian cancer progression [<xref ref-type="bibr" rid="CR37">37</xref>]. YTHDF2 triggers <italic>LATS1</italic> mRNA degradation by recognizing the m6A site of its mRNA induced by METTL3 in breast cancer cells [<xref ref-type="bibr" rid="CR38">38</xref>]. Likewise, YTHDF2 facilitates <italic>YAP</italic> mRNA decay via the RISC-AGO2 system, which could be regulated by m6A modification by ALKBH5 in lung cancer [<xref ref-type="bibr" rid="CR39">39</xref>]. In addition, MEX3A degrades <italic>KIBRA</italic> mRNA through a yet unknown mechanism to regulate Hippo pathway-dependent HCC [<xref ref-type="bibr" rid="CR40">40</xref>]. MSI2 modulates pancreatic cancer development through directly binding to the mRNAs of <italic>SAV1</italic> and <italic>MOB1</italic>, thereby controlling the translation and stability of <italic>SAV1</italic>, as well as the translation of MOB1 [<xref ref-type="bibr" rid="CR41">41</xref>]. The binding of hnRNPF to the <italic>YAP 3&#x02019;UTR</italic> directly results in <italic>YAP mRNA</italic> degradation [<xref ref-type="bibr" rid="CR42">42</xref>]. In summary, RBPs could regulate gene expression through altering target mRNA stability, which has been well-recognized as a canonical mechanism of RBPs.</p></sec><sec id="Sec6"><title>Translation</title><p id="Par18">It has been unraveled that RBPs play indispensable roles in the intricate process of mRNA translation [<xref ref-type="bibr" rid="CR20">20</xref>]. For instance, YTHDF1 promoted <italic>YAP</italic> mRNA translation by interacting with eIF3a upon depletion of m6A modification induced by ALKBH5 [<xref ref-type="bibr" rid="CR39">39</xref>]. In addition, as described earlier, MSI2 directly binds to and effectively diminishes the translation of <italic>SAV1</italic> and <italic>MOB1</italic>, thus regulating the progression of pancreatic ductal adenocarcinoma (PDAC) [<xref ref-type="bibr" rid="CR41">41</xref>]. Taken together, these studies indicate that RBPs could regulate the Hippo pathway through mediating target gene translation.</p></sec><sec id="Sec7"><title>Alternative splicing</title><p id="Par19">RBPs could also regulate Hippo pathway via a mechanism of alternative-splicing [<xref ref-type="bibr" rid="CR20">20</xref>]. For example, ESRP2 promotes expression of NF2 variants to activate Hippo kinases, leading to the increased activity of YAP/TAZ in chronically damaged liver [<xref ref-type="bibr" rid="CR43">43</xref>]. Additionally, B52 regulates tissue growth by modulating Yki-specific isoforms in <italic>Drosophila</italic> [<xref ref-type="bibr" rid="CR44">44</xref>]. RBFOX2 promotes the inclusion of exon 6 in <italic>TEAD1</italic> by directly binding to the pre-mRNA of <italic>TEAD1</italic>, resulting in deregulation of the Hippo pathway [<xref ref-type="bibr" rid="CR45">45</xref>]. Together, a mechanism of alternative-splicing could be utilized by RBPs to modulate the Hippo pathway.</p></sec></sec><sec id="Sec8"><title>Cooperation of RBPs, non-coding RNAs and transcription factors in the regulation of Hippo pathway</title><p id="Par20">It&#x02019;s well-documented that tight interaction between RBPs and non-coding RNAs whether cooperatively or competitively, could contribute significantly to the regulation of gene expression [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR46">46</xref>&#x02013;<xref ref-type="bibr" rid="CR49">49</xref>] (Fig. <xref rid="Fig1" ref-type="fig">1A&#x02013;C</xref>). For instance, RBM47 directly interacts with lncRNA <italic>HOXB-AS1</italic> to disrupt the formation of <italic>HOXB-AS1</italic>-p53 complex, facilitating the translocation of p53 from the cytoplasm into the nucleus [<xref ref-type="bibr" rid="CR50">50</xref>]. Besides, a series of studies have shown that RBP links lncRNA to target mRNA in multiple diseases [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>] (Fig. <xref rid="Fig1" ref-type="fig">1A</xref>). For example, lncRNA <italic>GMDS-AS1</italic> palliates the progression of lung adenocarcinoma (LUAD) by interacting with and recruiting TAF15 to stabilize <italic>SIRT1</italic> mRNA [<xref ref-type="bibr" rid="CR53">53</xref>]. Similarly, analogous scenarios are observed within the Hippo pathway. Our previous research reveals that Rox8 recruits and stabilizes miR-8-RISC to directly bind and collaboratively trigger the degradation of <italic>yki</italic> mRNA in <italic>Drosophila</italic>, a mechanism conserved from <italic>Drosophila</italic> to human [<xref ref-type="bibr" rid="CR19">19</xref>] (Fig. <xref rid="Fig1" ref-type="fig">1B</xref>). Of note, despites the intricate interplay between RBPs and non-coding RNAs, two RBPs may also execute synergistic effects (Fig. <xref rid="Fig1" ref-type="fig">1C</xref>). For instance, Lin28 recruits and cooperates with MSI2 to induce the mRNA decay of MST1/2 and LAST1/2 in TNBC [<xref ref-type="bibr" rid="CR36">36</xref>]. In conclusion, cooperation of RBPs, non-coding RNAs and transcription factors play crucial roles in the regulation of Hippo pathway.<fig id="Fig1"><label>Fig. 1</label><caption><title>Cooperation of RBPs, non-coding RNAs, TFs in the regulation of genes expression.</title><p><bold>A</bold> RBP cooperates with lncRNA. <bold>B</bold> RBP collaborates with microRNA-RISC complex. <bold>C</bold> Two RBP proteins exhibit the synergistic effect. <bold>D</bold> RBP-TF interaction regulate gene transcription.</p></caption><graphic xlink:href="41420_2025_2316_Fig1_HTML" id="d33e914"/></fig></p><p id="Par21">In addition, it has been reported that RBPs could collaborate with transcription factors (TFs) to directly bind to target DNA (Fig. <xref rid="Fig1" ref-type="fig">1D</xref>). For instance, RBM25 interacts with TF YY1 to bind on chromatin as a complex for altering gene transcription, as observed with targets such as NABP1, CX3CL1 and ATF7IP2 [<xref ref-type="bibr" rid="CR54">54</xref>]. Similarly, a recent study shows that RBM39 interacts with YAP/TAZ to activate downstream gene expression, thereby contributing to resistance against indisulam [<xref ref-type="bibr" rid="CR55">55</xref>]. Furthermore, it&#x02019;s uncovered that RBPs are predominantly localized on active chromatin regions involved in transcription control [<xref ref-type="bibr" rid="CR54">54</xref>]. On the whole, these findings suggest a general but indispensable role of RBPs in directly regulating genes transcription.</p></sec><sec id="Sec9"><title>RBPs function as downstream targets of the Hippo pathway</title><p id="Par22">Extensive research has elucidated that RBPs could function as pivotal downstream targets of specific signaling pathways, orchestrating a variety of biological processes [<xref ref-type="bibr" rid="CR20">20</xref>]. For instance, the PI3K/AKT/NF-kB signaling pathway activates <italic>Hu-antigen R</italic> (<italic>HuR</italic>) transcription in gastric cancer, promoting cellular growth and conferring resistance to apoptotic stresses [<xref ref-type="bibr" rid="CR56">56</xref>]. Besides, RBPs serve as mediators in the crosstalk between signaling pathways [<xref ref-type="bibr" rid="CR57">57</xref>]. For example, loss of the Hippo signaling activates JNK pathway via increasing TIA1 expression, thereby influencing cancer cell migration [<xref ref-type="bibr" rid="CR14">14</xref>] (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Actually, regulatory feedback loops exemplify an intricate mechanism of interplay. For instance, YTHDF3, a downstream target of the YAP-TEAD complex, physically interacts with and induces the degradation of m6A modified-<italic>lncRNAGAS5</italic>. This regulation further modulates YAP phosphorylation, which is essential for its ubiquitination in colorectal cancer cells [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>] (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Hence, these studies indicate that RBPs could be involved in various biological activities through acting as downstream targets of the Hippo pathway.<fig id="Fig2"><label>Fig. 2</label><caption><title>RBPs function downstream of the Hippo pathway.</title><p>Expression of TIA1 and YTHDF3 regulated by Hippo pathway modulate cancer cell behaviors, like cell invasion and cell proliferation.</p></caption><graphic xlink:href="41420_2025_2316_Fig2_HTML" id="d33e975"/></fig></p></sec><sec id="Sec10"><title>Stimuli-mediated RBP regulates the Hippo pathway</title><p id="Par23">For cellular stress adaptation, RBPs could be fine-tuned at multiple levels, including alterations in transcription activation, protein stability and binding activity through PTMs [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>] (Fig. <xref rid="Fig3" ref-type="fig">3A</xref>). Strikingly, RNA-binding elements within RBPs have been identified as hotspots for PTMs, representing a major mechanism underlying RBP dysfunction in diseases including cancer [<xref ref-type="bibr" rid="CR20">20</xref>]. For example, phosphorylation of hnRNPE1 by kinase B&#x003b2;/Akt2, which is mediated by transforming growth factor-&#x003b2; (TGF-&#x003b2;), alleviates the translational repression of target transcripts encoding DAB2 and ILEI, crucial mediators of epithelial-mesenchymal transition (EMT), thereby promoting the development of breast tumors [<xref ref-type="bibr" rid="CR62">62</xref>]. Glycogen synthase kinase 3 (GSK3) alters the conformation of RBM38 by phosphorylating it at serine 195, leading to the disruption of the interaction with the eukaryotic translation initiation factor 4E (eIF4E) on <italic>P53</italic> mRNA, and thus modulating P53 activity in breast and colorectal cancer cells [<xref ref-type="bibr" rid="CR63">63</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><title>Stimuli-mediated RBPs modulate the Hippo pathway.</title><p><bold>A</bold> Stress alters the expression or activity of RBPs, which then regulate output of Hippo pathway. <bold>B</bold> A feedback regulatory loop between the Hippo pathway and RBPs.</p></caption><graphic xlink:href="41420_2025_2316_Fig3_HTML" id="d33e1021"/></fig></p><p id="Par24">Further more in-depth research is warranted to investigate whether specific stimuli-mediated RBPs could regulate the Hippo pathway through analogous mechanisms as described above. Actually, in a distinctive scenario, YTHDF3, a direct target of the active YAP-TEAD complex by loss of Hippo signals, being an intrinsic intracellular stressor, modulates the degradation of <italic>lncRNAGAS5</italic>, which is crucial for YAP ubiquitination in the cytoplasm, thus forming a feedback loop between the Hippo pathway and YTHDF3 [<xref ref-type="bibr" rid="CR58">58</xref>] (Fig. <xref rid="Fig3" ref-type="fig">3B</xref>). Taken together, these data suggest RBPs may be responsive to extracellular stimuli or stresses, thereby regulating the Hippo pathway.</p></sec><sec id="Sec11"><title>Uncharacterized non-canonical RBPs to be deciphered</title><p id="Par25">A substantial fraction of TFs function as RBPs despite lacking canonical RNA binding domains (RBDs) like RRM and KH. For instance, Estrogen receptor &#x003b1; (ER&#x003b1;), a well-known hormone receptor and pivotal driver for breast cancers through the function of being a TF, has recently been identified as a novel RBP. ER&#x003b1; mediates alternative splicing of <italic>XBP1</italic> and translation of the <italic>eIF4G2</italic> and <italic>MCL1</italic> mRNAs [<xref ref-type="bibr" rid="CR61">61</xref>]. Of note, the RNABindRPlus database has accurately predicted the RNA-binding domain (RBD) of ER&#x003b1; [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. Strikingly, it has been speculated that at least half of TFs harbor a conserved RNA binding domain referred to as TF-ARMs (Arginine-rich motif sequence in TFs) [<xref ref-type="bibr" rid="CR65">65</xref>] (Fig. <xref rid="Fig4" ref-type="fig">4A</xref>). Furthermore, a number of RBPs do not rely on classical RBDs for RNA binding [<xref ref-type="bibr" rid="CR66">66</xref>], making the bioinformatic prediction of potential RBP&#x02013;RNA interactions challenging. In addition, RBPs exhibit distinct affinities and preferences for core motifs in the RNA sequences, often coupled with varying flanking bases outside the core sequence, which may be due to the modulation by PTMs, interacting co-partners and local sequence or structure context within the RNA [<xref ref-type="bibr" rid="CR67">67</xref>] (Fig. <xref rid="Fig4" ref-type="fig">4B</xref>). In essence, to identify potential non-canonical RBPs will undoubtedly contribute to a better understanding of crucial signaling-related development and diseases.<fig id="Fig4"><label>Fig. 4</label><caption><title>Perspective roles of RBPs in regulating the Hippo pathway.</title><p><bold>A</bold> TFs harbor non-canonical roles in directly binding to RNAs. <bold>B</bold> RBPs bind to non-canonical sites within RNA, often coupled with PTMs, RNA structure, or other proteins co-operations.</p></caption><graphic xlink:href="41420_2025_2316_Fig4_HTML" id="d33e1085"/></fig></p></sec><sec id="Sec12" sec-type="conclusion"><title>Conclusion</title><p id="Par26">On the whole, the review not only summarizes recent advances in the regulatory interplay between the Hippo pathway and RBPs, but expand a better understanding of potentially mechanistic regulation between RBPs and the Hippo pathway. Besides, the review also underscores the fine-tuning interaction between RBPs and non-coding RNAs in the regulation of gene expression. Moreover, we also highlight the necessity of non-canonical RBPs to be identified in future. In a word, the review may contribute to more cutting-edge research discoveries of RBPs regulating crucial signaling cascades like the Hippo pathway in the normal development and various diseases.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank the BioRender.com for the created cartoons in Figs. <xref rid="Fig1" ref-type="fig">1</xref>&#x02013;<xref rid="Fig4" ref-type="fig">4</xref>. Besides, we also thank all of the members of Guo lab for the discussion.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Shuchang Peng, Chenglin Li, Yanwen He and Xiaowei Guo wrote the manuscript. Yanwen He, Lei Xue and Xiaowei Guo revised and edited the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by the following funding: Hunan Provincial Natural Science Foundation for Excellent Young Scholars (2023JJ20029), Hunan Provincial Technological Innovation of Young Talents (2023RC3132), National Natural Science Foundation of China (32370760), the Scientific Research Project of Hunan Provincial Health Commission (C202302088169), Key Project of Developmental Biology and Breeding from Hunan Province of China (2022XKQ0205), and The Research Team for Reproduction Health and Translational Medicine of Hunan Normal University (2023JC101).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data relevant to this review are included in the references, tables and figures.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par27">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Justice</surname><given-names>RW</given-names></name><name><surname>Zilian</surname><given-names>O</given-names></name><name><surname>Woods</surname><given-names>DF</given-names></name><name><surname>Noll</surname><given-names>M</given-names></name><name><surname>Bryant</surname><given-names>PJ</given-names></name></person-group><article-title>The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation</article-title><source>Genes Dev</source><year>1995</year><volume>9</volume><fpage>534</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1101/gad.9.5.534</pub-id><pub-id pub-id-type="pmid">7698644</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 1995;9:534&#x02013;46.<pub-id pub-id-type="pmid">7698644</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>RA</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name></person-group><article-title>Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase</article-title><source>Development</source><year>1995</year><volume>121</volume><fpage>1053</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1242/dev.121.4.1053</pub-id><pub-id pub-id-type="pmid">7743921</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Xu T, Wang W, Zhang S, Stewart RA, Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 1995;121:1053&#x02013;63.<pub-id pub-id-type="pmid">7743921</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Lan</surname><given-names>T</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name></person-group><article-title>The Hippo signalling pathway and its implications in human health and diseases</article-title><source>Signal Transduct Target Ther</source><year>2022</year><volume>7</volume><fpage>376</fpage><pub-id pub-id-type="doi">10.1038/s41392-022-01191-9</pub-id><pub-id pub-id-type="pmid">36347846</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Fu M, Hu Y, Lan T, Guan KL, Luo T, Luo M. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther. 2022;7:376.<pub-id pub-id-type="pmid">36347846</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Mo</surname><given-names>JS</given-names></name><name><surname>Park</surname><given-names>HW</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><article-title>The Hippo signaling pathway in stem cell biology and cancer</article-title><source>EMBO Rep.</source><year>2014</year><volume>15</volume><fpage>642</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.15252/embr.201438638</pub-id><pub-id pub-id-type="pmid">24825474</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Mo JS, Park HW, Guan KL. The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep. 2014;15:642&#x02013;56.<pub-id pub-id-type="pmid">24825474</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Meng</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><article-title>The Hippo Pathway: Biology and Pathophysiology</article-title><source>Annu Rev Biochem</source><year>2019</year><volume>88</volume><fpage>577</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-013118-111829</pub-id><pub-id pub-id-type="pmid">30566373</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Ma S, Meng Z, Chen R, Guan KL. The Hippo Pathway: Biology and Pathophysiology. Annu Rev Biochem. 2019;88:577&#x02013;604.<pub-id pub-id-type="pmid">30566373</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>JM</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><article-title>Insights into recent findings and clinical application of YAP and TAZ in cancer</article-title><source>Nat Rev Cancer</source><year>2023</year><volume>23</volume><fpage>512</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1038/s41568-023-00579-1</pub-id><pub-id pub-id-type="pmid">37308716</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Franklin JM, Wu Z, Guan KL. Insights into recent findings and clinical application of YAP and TAZ in cancer. Nat Rev Cancer. 2023;23:512&#x02013;25.<pub-id pub-id-type="pmid">37308716</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name></person-group><article-title>RNA binding proteins: Linking mechanotransduction and tumor metastasis</article-title><source>Cancer Lett</source><year>2021</year><volume>496</volume><fpage>30</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2020.09.020</pub-id><pub-id pub-id-type="pmid">33007411</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Zhang Y, Li Z. RNA binding proteins: Linking mechanotransduction and tumor metastasis. Cancer Lett. 2021;496:30&#x02013;40.<pub-id pub-id-type="pmid">33007411</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Elbediwy</surname><given-names>A</given-names></name><name><surname>Vincent-Mistiaen</surname><given-names>ZI</given-names></name><name><surname>Thompson</surname><given-names>BJ</given-names></name></person-group><article-title>YAP and TAZ in epithelial stem cells: A sensor for cell polarity, mechanical forces and tissue damage</article-title><source>Bioessays</source><year>2016</year><volume>38</volume><fpage>644</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1002/bies.201600037</pub-id><pub-id pub-id-type="pmid">27173018</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Elbediwy A, Vincent-Mistiaen ZI, Thompson BJ. YAP and TAZ in epithelial stem cells: A sensor for cell polarity, mechanical forces and tissue damage. Bioessays. 2016;38:644&#x02013;53.<pub-id pub-id-type="pmid">27173018</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>V</given-names></name><name><surname>Plouffe</surname><given-names>SW</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><article-title>The Hippo pathway in organ development, homeostasis, and regeneration</article-title><source>Curr Opin Cell Biol</source><year>2017</year><volume>49</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2017.12.012</pub-id><pub-id pub-id-type="pmid">29316535</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Fu V, Plouffe SW, Guan KL. The Hippo pathway in organ development, homeostasis, and regeneration. Curr Opin Cell Biol. 2017;49:99&#x02013;107.<pub-id pub-id-type="pmid">29316535</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>D</given-names></name></person-group><article-title>The hippo signaling pathway in development and cancer</article-title><source>Dev Cell</source><year>2010</year><volume>19</volume><fpage>491</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2010.09.011</pub-id><pub-id pub-id-type="pmid">20951342</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010;19:491&#x02013;505.<pub-id pub-id-type="pmid">20951342</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Dai</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Xiong</surname><given-names>W</given-names></name><name><surname>Zeng</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name></person-group><article-title>The regulatory networks of the Hippo signaling pathway in cancer development</article-title><source>J Cancer</source><year>2021</year><volume>12</volume><fpage>6216</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.7150/jca.62402</pub-id><pub-id pub-id-type="pmid">34539895</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Wang M, Dai M, Wang D, Xiong W, Zeng Z, Guo C. The regulatory networks of the Hippo signaling pathway in cancer development. J Cancer. 2021;12:6216&#x02013;30.<pub-id pub-id-type="pmid">34539895</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Kwon Y, Vinayagam A, Sun X, Dephoure N, Gygi SP, Hong P, et al. The Hippo Signaling Pathway Interactome. 2013;342:737&#x02013;40.</mixed-citation></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>D</given-names></name></person-group><article-title>The Hippo Signaling Pathway in Development and Disease</article-title><source>Dev Cell</source><year>2019</year><volume>50</volume><fpage>264</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.06.003</pub-id><pub-id pub-id-type="pmid">31386861</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Zheng Y, Pan D. The Hippo Signaling Pathway in Development and Disease. Dev Cell. 2019;50:264&#x02013;82.<pub-id pub-id-type="pmid">31386861</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ji</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><etal/></person-group><article-title>Hippo signaling promotes JNK-dependent cell migration</article-title><source>Proc Natl Acad Sci</source><year>2017</year><volume>114</volume><fpage>1934</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.1621359114</pub-id><pub-id pub-id-type="pmid">28174264</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Ma X, Wang H, Ji J, Xu W, Sun Y, Li W, et al. Hippo signaling promotes JNK-dependent cell migration. Proc Natl Acad Sci. 2017;114:1934&#x02013;9.<pub-id pub-id-type="pmid">28174264</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Matia-Gonz&#x000e1;lez</surname><given-names>AM</given-names></name><name><surname>Jabre</surname><given-names>I</given-names></name><name><surname>Laing</surname><given-names>EE</given-names></name><name><surname>Gerber</surname><given-names>AP</given-names></name></person-group><article-title>Oxidative stress induces coordinated remodeling of RNA-enzyme interactions</article-title><source>iScience</source><year>2021</year><volume>24</volume><fpage>102753</fpage><pub-id pub-id-type="doi">10.1016/j.isci.2021.102753</pub-id><pub-id pub-id-type="pmid">34278261</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Matia-Gonz&#x000e1;lez AM, Jabre I, Laing EE, Gerber AP. Oxidative stress induces coordinated remodeling of RNA-enzyme interactions. iScience. 2021;24:102753.<pub-id pub-id-type="pmid">34278261</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Su</surname><given-names>P</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>T</given-names></name><etal/></person-group><article-title>YAP represses the TEAD-NF-&#x003ba;B complex and inhibits the growth of clear cell renal cell carcinoma</article-title><source>Sci Signal</source><year>2024</year><volume>17</volume><fpage>eadk0231</fpage><pub-id pub-id-type="doi">10.1126/scisignal.adk0231</pub-id><pub-id pub-id-type="pmid">38954637</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Li Z, Su P, Yu M, Zhang X, Xu Y, Jia T, et al. YAP represses the TEAD-NF-&#x003ba;B complex and inhibits the growth of clear cell renal cell carcinoma. Sci Signal. 2024;17:eadk0231.<pub-id pub-id-type="pmid">38954637</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Cho</surname><given-names>YS</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Zhuo</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name></person-group><article-title>The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth</article-title><source>Cell Discov</source><year>2022</year><volume>8</volume><fpage>103</fpage><pub-id pub-id-type="doi">10.1038/s41421-022-00465-4</pub-id><pub-id pub-id-type="pmid">36202785</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Li X, Cho YS, Zhu J, Zhuo S, Jiang J. The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth. Cell Discov. 2022;8:103.<pub-id pub-id-type="pmid">36202785</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhuo</surname><given-names>S</given-names></name><name><surname>Cho</surname><given-names>YS</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><etal/></person-group><article-title>YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth</article-title><source>Embo J</source><year>2023</year><volume>42</volume><fpage>e112184</fpage><pub-id pub-id-type="doi">10.15252/embj.2022112184</pub-id><pub-id pub-id-type="pmid">36588499</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Li X, Zhuo S, Cho YS, Liu Y, Yang Y, Zhu J, et al. YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth. Embo J. 2023;42:e112184.<pub-id pub-id-type="pmid">36588499</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Azad</surname><given-names>T</given-names></name><name><surname>Janse van Rensburg</surname><given-names>HJ</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Rox8 promotes microRNA-dependent yki messenger RNA decay</article-title><source>Proc Natl Acad Sci USA</source><year>2020</year><volume>117</volume><fpage>30520</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1073/pnas.2013449117</pub-id><pub-id pub-id-type="pmid">33203680</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Guo X, Sun Y, Azad T, Janse van Rensburg HJ, Luo J, Yang S, et al. Rox8 promotes microRNA-dependent yki messenger RNA decay. Proc Natl Acad Sci USA. 2020;117:30520&#x02013;30.<pub-id pub-id-type="pmid">33203680</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>B</given-names></name><name><surname>Billaud</surname><given-names>M</given-names></name><name><surname>Almeida</surname><given-names>R</given-names></name></person-group><article-title>RNA-Binding Proteins in Cancer: Old Players and New Actors</article-title><source>Trends Cancer</source><year>2017</year><volume>3</volume><fpage>506</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.trecan.2017.05.003</pub-id><pub-id pub-id-type="pmid">28718405</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Pereira B, Billaud M, Almeida R. RNA-Binding Proteins in Cancer: Old Players and New Actors. Trends Cancer. 2017;3:506&#x02013;28.<pub-id pub-id-type="pmid">28718405</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name></person-group><article-title>Research progress on RNA-binding proteins in breast cancer</article-title><source>Front Oncol</source><year>2022</year><volume>12</volume><fpage>974523</fpage><pub-id pub-id-type="doi">10.3389/fonc.2022.974523</pub-id><pub-id pub-id-type="pmid">36059653</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Chen Y, Qin H, Zheng L. Research progress on RNA-binding proteins in breast cancer. Front Oncol. 2022;12:974523.<pub-id pub-id-type="pmid">36059653</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Mach</surname><given-names>J</given-names></name><name><surname>Atkins</surname><given-names>M</given-names></name><name><surname>Gajewski</surname><given-names>KM</given-names></name><name><surname>Mottier-Pavie</surname><given-names>V</given-names></name><name><surname>Sansores-Garcia</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><etal/></person-group><article-title>Modulation of the Hippo pathway and organ growth by RNA processing proteins</article-title><source>Proc Natl Acad Sci USA</source><year>2018</year><volume>115</volume><fpage>10684</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.1807325115</pub-id><pub-id pub-id-type="pmid">30257938</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Mach J, Atkins M, Gajewski KM, Mottier-Pavie V, Sansores-Garcia L, Xie J, et al. Modulation of the Hippo pathway and organ growth by RNA processing proteins. Proc Natl Acad Sci USA. 2018;115:10684&#x02013;9.<pub-id pub-id-type="pmid">30257938</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>H</given-names></name><name><surname>Ni</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Xi</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>RNA-binding proteins in tumor progression</article-title><source>J Hematol Oncol</source><year>2020</year><volume>13</volume><fpage>90</fpage><pub-id pub-id-type="doi">10.1186/s13045-020-00927-w</pub-id><pub-id pub-id-type="pmid">32653017</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Qin H, Ni H, Liu Y, Yuan Y, Xi T, Li X, et al. RNA-binding proteins in tumor progression. J Hematol Oncol. 2020;13:90.<pub-id pub-id-type="pmid">32653017</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Parra</surname><given-names>AS</given-names></name><name><surname>Johnston</surname><given-names>CA</given-names></name></person-group><article-title>Emerging Roles of RNA-Binding Proteins in Neurodevelopment</article-title><source>J Dev Biol</source><year>2022</year><volume>10</volume><fpage>23</fpage><pub-id pub-id-type="doi">10.3390/jdb10020023</pub-id><pub-id pub-id-type="pmid">35735914</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Parra AS, Johnston CA. Emerging Roles of RNA-Binding Proteins in Neurodevelopment. J Dev Biol. 2022;10:23.<pub-id pub-id-type="pmid">35735914</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Lei</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>HT</given-names></name></person-group><article-title>RNA-binding proteins and cancer metastasis</article-title><source>Semin Cancer Biol</source><year>2022</year><volume>86</volume><fpage>748</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2022.03.018</pub-id><pub-id pub-id-type="pmid">35339667</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Wang S, Sun Z, Lei Z, Zhang HT. RNA-binding proteins and cancer metastasis. Semin Cancer Biol. 2022;86:748&#x02013;68.<pub-id pub-id-type="pmid">35339667</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Ciafr&#x000e8;</surname><given-names>SA</given-names></name><name><surname>Galardi</surname><given-names>S</given-names></name></person-group><article-title>microRNAs and RNA-binding proteins</article-title><source>RNA Biol</source><year>2014</year><volume>10</volume><fpage>934</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.4161/rna.24641</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Ciafr&#x000e8; SA, Galardi S. microRNAs and RNA-binding proteins. RNA Biol. 2014;10:934&#x02013;42.</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Nag</surname><given-names>S</given-names></name><name><surname>Goswami</surname><given-names>B</given-names></name><name><surname>Das Mandal</surname><given-names>S</given-names></name><name><surname>Ray</surname><given-names>PS</given-names></name></person-group><article-title>Cooperation and competition by RNA-binding proteins in cancer</article-title><source>Semin Cancer Biol</source><year>2022</year><volume>86</volume><fpage>286</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2022.02.023</pub-id><pub-id pub-id-type="pmid">35248729</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Nag S, Goswami B, Das Mandal S, Ray PS. Cooperation and competition by RNA-binding proteins in cancer. Semin Cancer Biol. 2022;86:286&#x02013;97.<pub-id pub-id-type="pmid">35248729</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Gong</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Chi</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>RNA-binding protein Dnd1 inhibits epithelial-mesenchymal transition and cancer stem cell-related traits on hepatocellular carcinoma cells</article-title><source>Biotechnol Lett</source><year>2017</year><volume>39</volume><fpage>1359</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1007/s10529-017-2375-5</pub-id><pub-id pub-id-type="pmid">28593479</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Xu W, Gong F, Zhang T, Chi B, Wang J. RNA-binding protein Dnd1 inhibits epithelial-mesenchymal transition and cancer stem cell-related traits on hepatocellular carcinoma cells. Biotechnol Lett. 2017;39:1359&#x02013;67.<pub-id pub-id-type="pmid">28593479</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>L</given-names></name><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Bu</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway</article-title><source>Cell Physiol Biochem</source><year>2018</year><volume>50</volume><fpage>437</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1159/000494155</pub-id><pub-id pub-id-type="pmid">30308519</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Bao L, Yuan L, Li P, Bu Q, Guo A, Zhang H, et al. A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway. Cell Physiol Biochem. 2018;50:437&#x02013;51.<pub-id pub-id-type="pmid">30308519</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name></person-group><article-title>RNA Binding Protein RNPC1 Suppresses the Stemness of Human Endometrial Cancer Cells via Stabilizing MST1/2 mRNA</article-title><source>Med Sci Monit</source><year>2020</year><volume>26</volume><fpage>e921389</fpage><pub-id pub-id-type="pmid">32088727</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Wu X, Wang Y, Zhong W, Cheng H, Tian Z. RNA Binding Protein RNPC1 Suppresses the Stemness of Human Endometrial Cancer Cells via Stabilizing MST1/2 mRNA. Med Sci Monit. 2020;26:e921389.<pub-id pub-id-type="pmid">32088727</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>JQ</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>ZS</given-names></name><name><surname>Zou</surname><given-names>C</given-names></name></person-group><article-title>RNA methylation and cancer treatment</article-title><source>Pharm Res</source><year>2021</year><volume>174</volume><fpage>105937</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2021.105937</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Yang B, Wang JQ, Tan Y, Yuan R, Chen ZS, Zou C. RNA methylation and cancer treatment. Pharm Res. 2021;174:105937.</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Motorin</surname><given-names>Y</given-names></name><name><surname>Helm</surname><given-names>M</given-names></name></person-group><article-title>RNA nucleotide methylation: 2021 update</article-title><source>Wiley Interdiscip Rev RNA</source><year>2022</year><volume>13</volume><fpage>e1691</fpage><pub-id pub-id-type="doi">10.1002/wrna.1691</pub-id><pub-id pub-id-type="pmid">34913259</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Motorin Y, Helm M. RNA nucleotide methylation: 2021 update. Wiley Interdiscip Rev RNA. 2022;13:e1691.<pub-id pub-id-type="pmid">34913259</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Nie</surname><given-names>Z</given-names></name><name><surname>Duan</surname><given-names>L</given-names></name><name><surname>Xiong</surname><given-names>Q</given-names></name><name><surname>Jin</surname><given-names>Z</given-names></name><etal/></person-group><article-title>The role of m6A modification in the biological functions and diseases</article-title><source>Signal Transduct Target Ther</source><year>2021</year><volume>6</volume><fpage>74</fpage><pub-id pub-id-type="doi">10.1038/s41392-020-00450-x</pub-id><pub-id pub-id-type="pmid">33611339</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.<pub-id pub-id-type="pmid">33611339</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Dong</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><etal/></person-group><article-title>N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells&#x02019; Properties and Lenvatinib Resistance Through WNT/&#x003b2;-Catenin and Hippo Signaling Pathways</article-title><source>Gastroenterology</source><year>2023</year><volume>164</volume><fpage>990</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2023.01.041</pub-id><pub-id pub-id-type="pmid">36764493</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Wang J, Yu H, Dong W, Zhang C, Hu M, Ma W, et al. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells&#x02019; Properties and Lenvatinib Resistance Through WNT/&#x003b2;-Catenin and Hippo Signaling Pathways. Gastroenterology. 2023;164:990&#x02013;1005.<pub-id pub-id-type="pmid">36764493</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Kong</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><etal/></person-group><article-title>IGF2BP1 enhances the stability of SIK2 mRNA through m(6)A modification to promote non-small cell lung cancer progression</article-title><source>Biochem Biophys Res Commun</source><year>2023</year><volume>684</volume><fpage>149113</fpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2023.10.045</pub-id><pub-id pub-id-type="pmid">37866243</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Xu Y, Xu L, Kong Y, Li K, Li J, Xu F, et al. IGF2BP1 enhances the stability of SIK2 mRNA through m(6)A modification to promote non-small cell lung cancer progression. Biochem Biophys Res Commun. 2023;684:149113.<pub-id pub-id-type="pmid">37866243</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>L</given-names></name><etal/></person-group><article-title>RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7</article-title><source>Oncogene</source><year>2022</year><volume>41</volume><fpage>1657</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1038/s41388-022-02198-w</pub-id><pub-id pub-id-type="pmid">35102250</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Zou H, Luo J, Guo Y, Liu Y, Wang Y, Deng L, et al. RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7. Oncogene. 2022;41:1657&#x02013;72.<pub-id pub-id-type="pmid">35102250</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>Z</given-names></name><name><surname>Luo</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><etal/></person-group><article-title>The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ</article-title><source>Mol Ther Nucleic Acids</source><year>2021</year><volume>26</volume><fpage>388</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1016/j.omtn.2021.07.012</pub-id><pub-id pub-id-type="pmid">34552820</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Liu T, Yang Y, Xie Z, Luo Q, Yang D, Liu X, et al. The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ. Mol Ther Nucleic Acids. 2021;26:388&#x02013;400.<pub-id pub-id-type="pmid">34552820</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><etal/></person-group><article-title>The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer</article-title><source>J Exp Clin Cancer Res</source><year>2023</year><volume>42</volume><fpage>10</fpage><pub-id pub-id-type="doi">10.1186/s13046-022-02581-1</pub-id><pub-id pub-id-type="pmid">36609396</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Xu Y, Song M, Hong Z, Chen W, Zhang Q, Zhou J, et al. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer. J Exp Clin Cancer Res. 2023;42:10.<pub-id pub-id-type="pmid">36609396</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>D</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><etal/></person-group><article-title>m(6)A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC</article-title><source>Mol Cancer</source><year>2020</year><volume>19</volume><fpage>40</fpage><pub-id pub-id-type="doi">10.1186/s12943-020-01161-1</pub-id><pub-id pub-id-type="pmid">32106857</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Jin D, Guo J, Wu Y, Yang L, Wang X, Du J, et al. m(6)A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Mol Cancer. 2020;19:40.<pub-id pub-id-type="pmid">32106857</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><etal/></person-group><article-title>MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way</article-title><source>Hepatol Int</source><year>2023</year><volume>17</volume><fpage>1500</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1007/s12072-023-10565-2</pub-id><pub-id pub-id-type="pmid">37460832</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Fang S, Zheng L, Chen X, Guo X, Ding Y, Ma J, et al. MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way. Hepatol Int. 2023;17:1500&#x02013;18.<pub-id pub-id-type="pmid">37460832</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Jiao</surname><given-names>F</given-names></name><name><surname>Cui</surname><given-names>J</given-names></name><etal/></person-group><article-title>RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer</article-title><source>Med Oncol</source><year>2020</year><volume>37</volume><fpage>84</fpage><pub-id pub-id-type="doi">10.1007/s12032-020-01384-8</pub-id><pub-id pub-id-type="pmid">32780197</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Yang H, Hu J, Chen J, Chen Z, Jiao F, Cui J, et al. RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer. Med Oncol. 2020;37:84.<pub-id pub-id-type="pmid">32780197</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>WK</given-names></name><name><surname>Hung</surname><given-names>LM</given-names></name><name><surname>Hou</surname><given-names>CW</given-names></name><name><surname>Chen</surname><given-names>JK</given-names></name></person-group><article-title>Heterogeneous ribonucleoprotein F regulates YAP expression via a G-tract in 3&#x02019;UTR</article-title><source>Biochim Biophys Acta Gene Regul Mech</source><year>2019</year><volume>1862</volume><fpage>12</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.bbagrm.2018.10.003</pub-id><pub-id pub-id-type="pmid">30312683</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Chu WK, Hung LM, Hou CW, Chen JK. Heterogeneous ribonucleoprotein F regulates YAP expression via a G-tract in 3&#x02019;UTR. Biochim Biophys Acta Gene Regul Mech. 2019;1862:12&#x02013;24.<pub-id pub-id-type="pmid">30312683</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Hyun</surname><given-names>J</given-names></name><name><surname>Al Abo</surname><given-names>M</given-names></name><name><surname>Dutta</surname><given-names>RK</given-names></name><name><surname>Oh</surname><given-names>SH</given-names></name><name><surname>Xiang</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><etal/></person-group><article-title>Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease</article-title><source>J Hepatol</source><year>2021</year><volume>75</volume><fpage>623</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2021.04.033</pub-id><pub-id pub-id-type="pmid">33964370</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Hyun J, Al Abo M, Dutta RK, Oh SH, Xiang K, Zhou X, et al. Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease. J Hepatol. 2021;75:623&#x02013;33.<pub-id pub-id-type="pmid">33964370</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>D</given-names></name><name><surname>de Toledo</surname><given-names>M</given-names></name><name><surname>Manchon</surname><given-names>L</given-names></name><name><surname>Tazi</surname><given-names>J</given-names></name><name><surname>Juge</surname><given-names>F</given-names></name></person-group><article-title>Modulation of Yorkie activity by alternative splicing is required for developmental stability</article-title><source>Embo j</source><year>2021</year><volume>40</volume><fpage>e104895</fpage><pub-id pub-id-type="doi">10.15252/embj.2020104895</pub-id><pub-id pub-id-type="pmid">33320356</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Srivastava D, de Toledo M, Manchon L, Tazi J, Juge F. Modulation of Yorkie activity by alternative splicing is required for developmental stability. Embo j. 2021;40:e104895.<pub-id pub-id-type="pmid">33320356</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Cho</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>I</given-names></name><name><surname>Cheon</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>C</given-names></name><etal/></person-group><article-title>RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling</article-title><source>Nucleic Acids Res</source><year>2022</year><volume>50</volume><fpage>8658</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac509</pub-id><pub-id pub-id-type="pmid">35699208</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Choi S, Lee HS, Cho N, Kim I, Cheon S, Park C, et al. RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling. Nucleic Acids Res. 2022;50:8658&#x02013;73.<pub-id pub-id-type="pmid">35699208</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Loffreda</surname><given-names>A</given-names></name><name><surname>Rigamonti</surname><given-names>A</given-names></name><name><surname>Barabino</surname><given-names>SM</given-names></name><name><surname>Lenzken</surname><given-names>SC</given-names></name></person-group><article-title>RNA-Binding Proteins in the Regulation of miRNA Activity: A Focus on Neuronal Functions</article-title><source>Biomolecules</source><year>2015</year><volume>5</volume><fpage>2363</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.3390/biom5042363</pub-id><pub-id pub-id-type="pmid">26437437</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Loffreda A, Rigamonti A, Barabino SM, Lenzken SC. RNA-Binding Proteins in the Regulation of miRNA Activity: A Focus on Neuronal Functions. Biomolecules. 2015;5:2363&#x02013;87.<pub-id pub-id-type="pmid">26437437</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Shaath</surname><given-names>H</given-names></name><name><surname>Vishnubalaji</surname><given-names>R</given-names></name><name><surname>Elango</surname><given-names>R</given-names></name><name><surname>Kardousha</surname><given-names>A</given-names></name><name><surname>Islam</surname><given-names>Z</given-names></name><name><surname>Qureshi</surname><given-names>R</given-names></name><etal/></person-group><article-title>Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches</article-title><source>Semin Cancer Biol</source><year>2022</year><volume>86</volume><fpage>325</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2022.05.013</pub-id><pub-id pub-id-type="pmid">35643221</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Shaath H, Vishnubalaji R, Elango R, Kardousha A, Islam Z, Qureshi R, et al. Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches. Semin Cancer Biol. 2022;86:325&#x02013;45.<pub-id pub-id-type="pmid">35643221</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Meng D, Zhao S, Wu L, Ma X, Zhao D, Li Z. LINC00641 impeded the malignant biological behaviors of papillary thyroid carcinoma cells via interacting with IGF2BP1 to reduce GLI1 mRNA stability. Hum Exp Toxicol. 2023;42:9603271231180856.</mixed-citation></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>A</given-names></name><name><surname>Yue</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination</article-title><source>Cell death Discov</source><year>2023</year><volume>9</volume><fpage>169</fpage><pub-id pub-id-type="doi">10.1038/s41420-023-01459-1</pub-id><pub-id pub-id-type="pmid">37198207</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Xia A, Yue Q, Zhu M, Xu J, Liu S, Wu Y, et al. The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination. Cell death Discov. 2023;9:169.<pub-id pub-id-type="pmid">37198207</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Q</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhuang</surname><given-names>W</given-names></name></person-group><article-title>RBM47 restrains renal cell carcinoma progression and chemoresistance through interacting with lncRNA HOXB-AS1</article-title><source>Cell death Discov</source><year>2023</year><volume>9</volume><fpage>329</fpage><pub-id pub-id-type="doi">10.1038/s41420-023-01623-7</pub-id><pub-id pub-id-type="pmid">37660095</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Su Q, Pan Z, Chen H, Chen J, Zhang Y, Zhuang W. RBM47 restrains renal cell carcinoma progression and chemoresistance through interacting with lncRNA HOXB-AS1. Cell death Discov. 2023;9:329.<pub-id pub-id-type="pmid">37660095</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>P</given-names></name><name><surname>Xing</surname><given-names>L</given-names></name><name><surname>Hong</surname><given-names>X</given-names></name><name><surname>Chang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title>LncRNA PITPNA&#x02010;AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNA</article-title><source>Cancer Med</source><year>2020</year><volume>9</volume><fpage>7706</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1002/cam4.3268</pub-id><pub-id pub-id-type="pmid">32871048</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Ren P, Xing L, Hong X, Chang L, Zhang H. LncRNA PITPNA&#x02010;AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNA. Cancer Med. 2020;9:7706&#x02013;16.<pub-id pub-id-type="pmid">32871048</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name></person-group><article-title>LncRNA APOA1-AS facilitates proliferation and migration and represses apoptosis of VSMCs through TAF15-mediated SMAD3 mRNA stabilization</article-title><source>Cell Cycle</source><year>2021</year><volume>20</volume><fpage>1642</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1080/15384101.2021.1951940</pub-id><pub-id pub-id-type="pmid">34382908</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Wang J, Cai Y, Lu H, Zhang F, Zheng J. LncRNA APOA1-AS facilitates proliferation and migration and represses apoptosis of VSMCs through TAF15-mediated SMAD3 mRNA stabilization. Cell Cycle. 2021;20:1642&#x02013;52.<pub-id pub-id-type="pmid">34382908</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Duan</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Duan</surname><given-names>C</given-names></name></person-group><article-title>lncRNA GMDS-AS1 restrains lung adenocarcinoma progression via recruiting TAF15 protein to stabilize SIRT1 mRNA</article-title><source>Epigenomics</source><year>2023</year><volume>15</volume><fpage>417</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.2217/epi-2022-0432</pub-id><pub-id pub-id-type="pmid">37309595</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Peng W, Jiang J, Fu J, Duan H, Wang J, Duan C. lncRNA GMDS-AS1 restrains lung adenocarcinoma progression via recruiting TAF15 protein to stabilize SIRT1 mRNA. Epigenomics. 2023;15:417&#x02013;34.<pub-id pub-id-type="pmid">37309595</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>J-Y</given-names></name><name><surname>Liang</surname><given-names>Z</given-names></name><name><surname>Luo</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Lu</surname><given-names>ZJ</given-names></name><etal/></person-group><article-title>Pervasive Chromatin-RNA Binding Protein Interactions Enable RNA-Based Regulation of Transcription</article-title><source>Cell</source><year>2019</year><volume>178</volume><fpage>107</fpage><lpage>121.e118</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.06.001</pub-id><pub-id pub-id-type="pmid">31251911</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Xiao R, Chen J-Y, Liang Z, Luo D, Chen G, Lu ZJ, et al. Pervasive Chromatin-RNA Binding Protein Interactions Enable RNA-Based Regulation of Transcription. Cell. 2019;178:107&#x02013;121.e118.<pub-id pub-id-type="pmid">31251911</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Ando</surname><given-names>T</given-names></name><name><surname>Okamoto</surname><given-names>K</given-names></name><name><surname>Ueda</surname><given-names>Y</given-names></name><name><surname>Kataoka</surname><given-names>N</given-names></name><name><surname>Shintani</surname><given-names>T</given-names></name><name><surname>Yanamoto</surname><given-names>S</given-names></name><etal/></person-group><article-title>YAP/TAZ interacts with RBM39 to confer resistance against indisulam</article-title><source>Oncogenesis</source><year>2024</year><volume>13</volume><fpage>25</fpage><pub-id pub-id-type="doi">10.1038/s41389-024-00527-0</pub-id><pub-id pub-id-type="pmid">39004623</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Ando T, Okamoto K, Ueda Y, Kataoka N, Shintani T, Yanamoto S, et al. YAP/TAZ interacts with RBM39 to confer resistance against indisulam. Oncogenesis. 2024;13:25.<pub-id pub-id-type="pmid">39004623</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>MJ</given-names></name><name><surname>Ryu</surname><given-names>BK</given-names></name><name><surname>Lee</surname><given-names>MG</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Ha</surname><given-names>TK</given-names></name><etal/></person-group><article-title>NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis</article-title><source>Gastroenterology</source><year>2008</year><volume>135</volume><fpage>2030</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2008.08.009</pub-id><pub-id pub-id-type="pmid">18824170</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Kang MJ, Ryu BK, Lee MG, Han J, Lee JH, Ha TK, et al. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis. Gastroenterology. 2008;135:2030&#x02013;42. 2042.e2031-2033.<pub-id pub-id-type="pmid">18824170</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Venigalla</surname><given-names>RK</given-names></name><name><surname>Turner</surname><given-names>M</given-names></name></person-group><article-title>RNA-binding proteins as a point of convergence of the PI3K and p38 MAPK pathways</article-title><source>Front Immunol</source><year>2012</year><volume>3</volume><fpage>398</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2012.00398</pub-id><pub-id pub-id-type="pmid">23272005</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Venigalla RK, Turner M. RNA-binding proteins as a point of convergence of the PI3K and p38 MAPK pathways. Front Immunol. 2012;3:398.<pub-id pub-id-type="pmid">23272005</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>W</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>A</given-names></name><etal/></person-group><article-title>Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3</article-title><source>Mol Cancer</source><year>2019</year><volume>18</volume><fpage>143</fpage><pub-id pub-id-type="doi">10.1186/s12943-019-1079-y</pub-id><pub-id pub-id-type="pmid">31619268</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Ni W, Yao S, Zhou Y, Liu Y, Huang P, Zhou A, et al. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3. Mol Cancer. 2019;18:143.<pub-id pub-id-type="pmid">31619268</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ji</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name></person-group><article-title>The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms</article-title><source>J Exp Clin Cancer Res</source><year>2022</year><volume>41</volume><fpage>202</fpage><pub-id pub-id-type="doi">10.1186/s13046-022-02403-4</pub-id><pub-id pub-id-type="pmid">35701841</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Zhang Y, Wang Y, Ji H, Ding J, Wang K. The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms. J Exp Clin Cancer Res. 2022;41:202.<pub-id pub-id-type="pmid">35701841</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Corre</surname><given-names>M</given-names></name><name><surname>Lebreton</surname><given-names>A</given-names></name></person-group><article-title>Regulation of cold-inducible RNA-binding protein (CIRBP) in response to cellular stresses</article-title><source>Biochimie</source><year>2024</year><volume>217</volume><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2023.04.003</pub-id><pub-id pub-id-type="pmid">37037339</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Corre M, Lebreton A. Regulation of cold-inducible RNA-binding protein (CIRBP) in response to cellular stresses. Biochimie. 2024;217:3&#x02013;9.<pub-id pub-id-type="pmid">37037339</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Huangyang</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xue</surname><given-names>L</given-names></name><name><surname>Devericks</surname><given-names>E</given-names></name><name><surname>Nguyen</surname><given-names>HG</given-names></name><etal/></person-group><article-title>ER&#x003b1; is an RNA-binding protein sustaining tumor cell survival and drug resistance</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>5215</fpage><lpage>5229.e5217</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.08.036</pub-id><pub-id pub-id-type="pmid">34559986</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Xu Y, Huangyang P, Wang Y, Xue L, Devericks E, Nguyen HG, et al. ER&#x003b1; is an RNA-binding protein sustaining tumor cell survival and drug resistance. Cell. 2021;184:5215&#x02013;5229.e5217.<pub-id pub-id-type="pmid">34559986</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhury</surname><given-names>A</given-names></name><name><surname>Hussey</surname><given-names>GS</given-names></name><name><surname>Ray</surname><given-names>PS</given-names></name><name><surname>Jin</surname><given-names>G</given-names></name><name><surname>Fox</surname><given-names>PL</given-names></name><name><surname>Howe</surname><given-names>PH</given-names></name></person-group><article-title>TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI</article-title><source>Nat Cell Biol</source><year>2010</year><volume>12</volume><fpage>286</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1038/ncb2029</pub-id><pub-id pub-id-type="pmid">20154680</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Chaudhury A, Hussey GS, Ray PS, Jin G, Fox PL, Howe PH. TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol. 2010;12:286&#x02013;93.<pub-id pub-id-type="pmid">20154680</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Cho</surname><given-names>SJ</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1</article-title><source>Genes Dev</source><year>2013</year><volume>27</volume><fpage>2246</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1101/gad.221739.113</pub-id><pub-id pub-id-type="pmid">24142875</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Zhang M, Zhang J, Chen X, Cho SJ, Chen X. Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1. Genes Dev. 2013;27:2246&#x02013;58.<pub-id pub-id-type="pmid">24142875</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Walia</surname><given-names>RR</given-names></name><name><surname>Xue</surname><given-names>LC</given-names></name><name><surname>Wilkins</surname><given-names>K</given-names></name><name><surname>El-Manzalawy</surname><given-names>Y</given-names></name><name><surname>Dobbs</surname><given-names>D</given-names></name><name><surname>Honavar</surname><given-names>V</given-names></name></person-group><article-title>RNABindRPlus: a predictor that combines machine learning and sequence homology-based methods to improve the reliability of predicted RNA-binding residues in proteins</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e97725</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0097725</pub-id><pub-id pub-id-type="pmid">24846307</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Walia RR, Xue LC, Wilkins K, El-Manzalawy Y, Dobbs D, Honavar V. RNABindRPlus: a predictor that combines machine learning and sequence homology-based methods to improve the reliability of predicted RNA-binding residues in proteins. PLoS One. 2014;9:e97725.<pub-id pub-id-type="pmid">24846307</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Oksuz</surname><given-names>O</given-names></name><name><surname>Henninger</surname><given-names>JE</given-names></name><name><surname>Warneford-Thomson</surname><given-names>R</given-names></name><name><surname>Zheng</surname><given-names>MM</given-names></name><name><surname>Erb</surname><given-names>H</given-names></name><name><surname>Vancura</surname><given-names>A</given-names></name><etal/></person-group><article-title>Transcription factors interact with RNA to regulate genes</article-title><source>Mol Cell</source><year>2023</year><volume>83</volume><fpage>2449</fpage><lpage>2463.e2413</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2023.06.012</pub-id><pub-id pub-id-type="pmid">37402367</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Oksuz O, Henninger JE, Warneford-Thomson R, Zheng MM, Erb H, Vancura A, et al. Transcription factors interact with RNA to regulate genes. Mol Cell. 2023;83:2449&#x02013;2463.e2413.<pub-id pub-id-type="pmid">37402367</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Castello</surname><given-names>A</given-names></name><name><surname>Fischer</surname><given-names>B</given-names></name><name><surname>Eichelbaum</surname><given-names>K</given-names></name><name><surname>Horos</surname><given-names>R</given-names></name><name><surname>Beckmann</surname><given-names>BM</given-names></name><name><surname>Strein</surname><given-names>C</given-names></name><etal/></person-group><article-title>Insights into RNA biology from an atlas of mammalian mRNA-binding proteins</article-title><source>Cell</source><year>2012</year><volume>149</volume><fpage>1393</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.04.031</pub-id><pub-id pub-id-type="pmid">22658674</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Castello A, Fischer B, Eichelbaum K, Horos R, Beckmann BM, Strein C, et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell. 2012;149:1393&#x02013;406.<pub-id pub-id-type="pmid">22658674</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Lukong</surname><given-names>KE</given-names></name><name><surname>Chang</surname><given-names>K-w</given-names></name><name><surname>Khandjian</surname><given-names>EW</given-names></name><name><surname>Richard</surname><given-names>S</given-names></name></person-group><article-title>RNA-binding proteins in human genetic disease</article-title><source>Trends Genet</source><year>2008</year><volume>24</volume><fpage>416</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2008.05.004</pub-id><pub-id pub-id-type="pmid">18597886</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Lukong KE, Chang K-w, Khandjian EW, Richard S. RNA-binding proteins in human genetic disease. Trends Genet. 2008;24:416&#x02013;25.<pub-id pub-id-type="pmid">18597886</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>